IVA logo

Inventiva SA (IVA) Company Overview

Profile

Full Name:

Inventiva S.A.

Sector:

Healthcare

Industry:

Biotechnology

Country:

France

IPO:

July 10, 2020

Indexes:

Not included

Website:

http://www.inventivapharma.com

Description:

Inventiva SA is a biopharmaceutical company focused on developing innovative treatments for diseases with high unmet medical needs. They specialize in research and development of new drugs, particularly for metabolic and fibrotic diseases, aiming to improve patients' lives through advanced therapies.

Key Details

Price

$3.17

Market Cap

$165.99 M(Small cap)

Last Dividend

-

TTM Dividend Yield

-

Annual Revenue

$18.92 M(+47.31% YoY)

Annual EPS

-$2.63(-90.42% YoY)

PE Ratio

-

Annual ROE

-1789.46%

Annual Debt To Equity

-0.97

Beta

0.49

Events Calendar

Earnings

Next earnings date:

Mar 26, 2025

Recent quarterly earnings:

Sep 25, 2024

Recent annual earnings:

Mar 27, 2024
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

N/A

Analyst ratings

Recent major analysts updates

Jan 30, 25 HC Wainwright & Co.
Buy
Nov 22, 24 Stifel
Buy
Nov 12, 24 UBS
Neutral
Oct 15, 24 HC Wainwright & Co.
Buy
Sep 26, 24 Stifel
Buy
Sep 26, 24 HC Wainwright & Co.
Buy
Apr 8, 24 Canaccord Genuity
Buy
Apr 1, 24 HC Wainwright & Co.
Buy
Mar 20, 24 HC Wainwright & Co.
Buy
Mar 8, 24 HC Wainwright & Co.
Buy

Screeners with IVA included

Growing Shares Outstanding
Best performing stocks last 3 months
Healthcare sector
All stocks
Biotechnology industry
Small cap stocks
Stocks above SMA 200
NASDAQ earnings calendar
Stocks with high RSI
Stocks above SMA 50

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Current Price

$3.17
IVA price is $3.17

Price All-time High

$19.00
IVA price is currently -83.32% below its historical high of $19.00

Price Analysts Target

-
IVA price consensus analysts' forecast is unknown

Price Most Recent Change

-2.76%
IVA price was down -2.76% on Feb 28, 2025

Price YTD Change

+47.44%
IVA price is up +47.44% since January 1st

Price 3-Year Change

-73.37%
IVA price is down -73.37% over the past 3 years

Market cap

Market Cap

$165.99 M
IVA market capitalization is $165.99 million

Market Cap 3-Year Change

-65.89%
IVA market capitalization is down -65.89% over the past 3 years

Market Cap All-time High

$733.98 M
IVA market capitalization is currently -77.39% below its historical high of $733.98 million

Market Cap Sector Rank

52.55%
IVA market capitalization is higher than 52.55% of companies in Healthcare sector

Technical

Beta

0.49
IVA beta is 0.49

200-day SMA

$2.57
IVA price is currently +23.53% above its 200-day simple moving average

14-day RSI

73.42
IVA 14-day relative strength index is 73.42

30-day Relative Volume

0.69
IVA 30-day relative volume is 0.69

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Annual Revenue

$18.92 M
IVA annual revenue is $18.92 million

Annual Revenue Analysts Estimate

$6.71 M
IVA annual revenue is currently +182.06% higher than the consensus analysts' forecast

Annual Revenue 1-Year Change

+47.31%
IVA annual revenue is up +47.31% year-on-year

Annual Revenue Sector Rank

35.65%
IVA annual revenue is higher than 35.65% of companies in Healthcare sector

Profit

Annual Gross Profit

-
IVA annual gross profit value is unknown

Annual Gross Margin

-
IVA annual gross profit margin value is unknown

Annual Operating Profit

-$111.15 M
IVA annual operating income is -$111.15 million

Annual Operating Margin

-587.43%
IVA annual operating profit margin is -587.43%

Annual Net Income

-$119.55 M
IVA annual net profit is -$119.55 million

Annual Net Margin

-631.84%
IVA annual net profit margin is -631.84%

EPS

Annual EPS

-$2.63
IVA annual earnings per share is -$2.63

Annual EPS Analysts Estimate

-$1.94
IVA annual earnings per share is currently +35.36% higher than the consensus analysts' forecast

Annual EPS 1-Year Change

-90.42%
IVA annual earnings per share is down -90.42% year-on-year

Annual EPS Sector Rank

35.99%
IVA annual earnings per share is higher than 35.99% of companies in Healthcare sector

ROA & ROE

Annual ROA

-118.78%
IVA annual return on assets is -118.78%

Annual ROE

-1789.46%
IVA annual return on equity is -1789.46%

EBIT & EBITDA

Annual EBIT

-$113.28 M
IVA annual earnings before interest & taxes is -$113.28 million

Annual EBITDA

-$110.47 M
IVA annual EBITDA is -$110.47 million

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE Ratio

-
IVA price to earnings ratio value is unknown

PE Ratio Sector Rank

-
IVA price to earnings ratio is unknown

PB Ratio

PB Ratio

-1.96
IVA price to book ratio is -1.96

PB Ratio Sector Rank

6.92%
IVA price to book ratio is higher than 6.92% of companies in Healthcare sector

PS Ratio

PS Ratio

-
IVA price to sales ratio value is unknown

PS Ratio Sector Rank

-
IVA price to sales ratio is unknown

Enterprise value

Enterprise Value

$211.46 M
IVA enterprise value is $211.46 million

Enterprise Value Sector Rank

57.29%
IVA enterprise value is higher than 57.29% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-
IVA EV/EBITDA value is unknown

EV/EBITDA Sector Rank

-
IVA EV/EBITDA is unknown

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Annual Current Ratio

0.96
IVA annual current ratio is 0.96

Annual Quick Ratio

0.95
IVA annual quick ratio is 0.95

Leverage

Annual Debt To Equity

-0.97
IVA annual debt to equity ratio is -0.97

Annual Interest Coverage Ratio

-20.21
IVA annual interest coverage ratio is -20.21

Risk & Stability

Piotroski F-Score

-
IVA piotroski f-score value is unknown

Altman Z-Score

-5.99
IVA altman z-score is -5.99

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Annual Total Assets

$76.89 M
IVA annual total assets is $76.89 million

Annual Non Current Assets

$23.63 M
IVA annual long term assets is $23.63 million

Annual Current Assets

$53.27 M
IVA annual total current assets is $53.27 million

Annual Cash & Cash Equivalents

$29.76 M
IVA annual cash & cash equivalents is $29.76 million

Equity

Annual Book Value

-$35.41 M
IVA annual book value is -$35.41 million

Annual Working Capital

-$2.18 M
IVA annual working capital is -$2.18 million

Liabilities

Annual Total Liabilities

$112.30 M
IVA annual total liabilities is $112.30 million

Annual Total Long Term Liabilities

$56.86 M
IVA annual total long term liabilities is $56.86 million

Annual Current Liabilities

$55.44 M
IVA annual total current liabilities is $55.44 million

Annual Accounts Payable

$41.65 M
IVA annual accounts payable is $41.65 million

Debt

Annual Total Debt

$41.44 M
IVA annual total debt is $41.44 million

Annual Total Debt 1-Year Change

+11.96%
IVA annual total debt is up +11.96% year-on-year

Annual Long Term Debt

$35.57 M
IVA annual long term debt is $35.57 million

Annual Short Term Debt

$5.87 M
IVA annual short term debt is $5.87 million

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Annual Total Expenses

$130.07 M
IVA annual total expenses is $130.07 million

Annual Operating Expenses

$130.07 M
IVA annual total operating expenses is $130.07 million

Annual Cost Of Goods Sold

-
IVA annual cost of goods sold value is unknown

Annual SGA

$16.90 M
IVA annual SGA is $16.90 million

Annual D&A

$2.81 M
IVA annual depreciation & amortization is $2.81 million

Annual Interest Expense

$5.61 M
IVA annual interest expense is $5.61 million

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Annual CFO

-$88.36 M
IVA annual cash flow from operations is -$88.36 million

Annual CFO 1-Year Change

-86.48%
IVA annual cash flow from operations is down -86.48% year-on-year

Annual CFI

-$8.37 M
IVA annual cash flow from investing activities is -$8.37 million

Annual CFI 1-Year Change

-189.49%
IVA annual cash flow from investing activities is down -189.49% year-on-year

Annual CFF

$31.48 M
IVA annual cash flow from financing activities is $31.48 million

Annual CFF 1-Year Change

-19.9%
IVA annual cash flow from financing activities is down -19.9% year-on-year

Free CashFlow

Annual FCF

-$88.94 M
IVA annual free cash flow is -$88.94 million

Annual FCF 1-Year Change

-85.4%
IVA annual free cash flow is down -85.4% year-on-year

CAPEX

Annual CAPEX

$584.60 K
IVA annual capital expenditures is $584.60 thousand

Annual CAPEX 1-Year Change

-1.18%
IVA annual capital expenditures is down -1.18% year-on-year

Institutional Ownership

Similar stocks

ENTA logo
Enanta Pharmaceuticals (ENTA)
MYO logo
Myomo (MYO)
NBTX logo
Nanobiotix SA (NBTX)
Acrivon Therapeutics (ACRV)
NAUT logo
Nautilus Biotechnology (NAUT)
NKTR logo
Nektar Therapeutics (NKTR)
MGNX logo
MacroGenics (MGNX)
ALEC logo
Alector (ALEC)
INFU logo
InfuSystem Holdings (INFU)

FAQ

  • What is the ticker symbol for Inventiva SA?
  • Does Inventiva SA pay dividends?
  • What sector is Inventiva SA in?
  • What industry is Inventiva SA in?
  • What country is Inventiva SA based in?
  • When did Inventiva SA go public?
  • Is Inventiva SA in the S&P 500?
  • Is Inventiva SA in the NASDAQ 100?
  • Is Inventiva SA in the Dow Jones?
  • When was Inventiva SA's last earnings report?
  • When does Inventiva SA report earnings?

What is the ticker symbol for Inventiva SA?

The ticker symbol for Inventiva SA is NASDAQ:IVA

Does Inventiva SA pay dividends?

No, Inventiva SA does not pay dividends

What sector is Inventiva SA in?

Inventiva SA is in the Healthcare sector

What industry is Inventiva SA in?

Inventiva SA is in the Biotechnology industry

What country is Inventiva SA based in?

Inventiva SA is headquartered in France

When did Inventiva SA go public?

Inventiva SA's initial public offering (IPO) was on July 10, 2020

Is Inventiva SA in the S&P 500?

No, Inventiva SA is not included in the S&P 500 index

Is Inventiva SA in the NASDAQ 100?

No, Inventiva SA is not included in the NASDAQ 100 index

Is Inventiva SA in the Dow Jones?

No, Inventiva SA is not included in the Dow Jones index

When was Inventiva SA's last earnings report?

Inventiva SA's most recent earnings report was on Sep 25, 2024

When does Inventiva SA report earnings?

The next expected earnings date for Inventiva SA is Mar 26, 2025